Eisenman D, Swindle S
Appl Biosaf. 2023; 27(4):201-209.
PMID: 37020567
PMC: 10068672.
DOI: 10.1089/apb.2022.0022.
Grohman J, Gorelick R, Kottegoda S, Allbritton N, Rein A, Weeks K
J Virol. 2014; 88(11):6061-8.
PMID: 24623442
PMC: 4093898.
DOI: 10.1128/JVI.03277-13.
Aloia A, Duffy L, Pak V, Lee K, Sanchez-Martinez S, Derse D
Gene Ther. 2012; 20(2):169-76.
PMID: 22402321
PMC: 3374051.
DOI: 10.1038/gt.2012.18.
Rein A
Adv Virol. 2012; 2011:403419.
PMID: 22312342
PMC: 3265304.
DOI: 10.1155/2011/403419.
Rulli Jr S, Mirro J, Hill S, Lloyd P, Gorelick R, Coffin J
J Virol. 2008; 82(13):6566-75.
PMID: 18448535
PMC: 2447093.
DOI: 10.1128/JVI.01357-07.
Effects of blocking individual maturation cleavages in murine leukemia virus gag.
Oshima M, Muriaux D, Mirro J, Nagashima K, Dryden K, Yeager M
J Virol. 2004; 78(3):1411-20.
PMID: 14722296
PMC: 321369.
DOI: 10.1128/jvi.78.3.1411-1420.2004.
Reversal by dithiothreitol treatment of the block in murine leukemia virus maturation induced by disulfide cross-linking.
Campbell S, Oshima M, Mirro J, Nagashima K, Rein A
J Virol. 2002; 76(19):10050-5.
PMID: 12208984
PMC: 136531.
DOI: 10.1128/jvi.76.19.10050-10055.2002.
A chimeric human T-cell lymphotropic virus type 1 with the envelope glycoprotein of Moloney murine leukemia virus is infectious for murine cells.
Delebecque F, Pramberger K, Prevost M, Brahic M, Tangy F
J Virol. 2002; 76(15):7883-9.
PMID: 12097602
PMC: 136376.
DOI: 10.1128/jvi.76.15.7883-7889.2002.
Therapeutic effect of a Gag-nuclease fusion protein against retroviral infection in vivo.
Schumann G, Hermankova M, Cannon K, Mankowski J, Boeke J
J Virol. 2001; 75(15):7030-41.
PMID: 11435583
PMC: 114431.
DOI: 10.1128/JVI.75.15.7030-7041.2001.
Virological properties and nucleotide sequences of Cas-E-type endogenous ecotropic murine leukemia viruses in South Asian wild mice, Mus musculus castaneus.
Ikeda H, Kato K, Kitani H, Suzuki T, Yoshida T, Inaguma Y
J Virol. 2001; 75(11):5049-58.
PMID: 11333885
PMC: 114909.
DOI: 10.1128/JVI.75.11.5049-5058.2001.
Properties of the naturally occurring soluble surface glycoprotein of ecotropic murine leukemia virus: binding specificity and possible conformational change after binding to receptor.
Ikeda H, Kato K, Suzuki T, Kitani H, Matsubara Y, Watanabe R
J Virol. 2000; 74(4):1815-26.
PMID: 10644355
PMC: 111660.
DOI: 10.1128/jvi.74.4.1815-1826.2000.
Threshold number of provirus copies required per cell for efficient virus production and interference in moloney murine leukemia virus-infected NIH 3T3 cells.
Odawara T, Oshima M, Doi K, Iwamoto A, Yoshikura H
J Virol. 1998; 72(7):5414-24.
PMID: 9620996
PMC: 110173.
DOI: 10.1128/JVI.72.7.5414-5424.1998.
Cryptococcus neoformans infection in mice previously infected with LP-BM5 MuLV, the agent of murine AIDS (MAIDS).
Lacroix C, Chau F, Carbon C, Sinet M, Derouin F
Clin Exp Immunol. 1997; 110(2):196-202.
PMID: 9367402
PMC: 2265516.
DOI: 10.1111/j.1365-2249.1997.tb08317.x.
Expression of a murine leukemia virus Gag-Escherichia coli RNase HI fusion polyprotein significantly inhibits virus spread.
VanBrocklin M, Ferris A, Hughes S, Federspiel M
J Virol. 1997; 71(4):3312-8.
PMID: 9060701
PMC: 191470.
DOI: 10.1128/JVI.71.4.3312-3318.1997.
Inactivation of murine leukemia virus by compounds that react with the zinc finger in the viral nucleocapsid protein.
Rein A, Ott D, Mirro J, Arthur L, Rice W, Henderson L
J Virol. 1996; 70(8):4966-72.
PMID: 8764002
PMC: 190449.
DOI: 10.1128/JVI.70.8.4966-4972.1996.
Therapeutic effect of Gag-nuclease fusion protein on retrovirus-infected cell cultures.
Schumann G, Qin L, Rein A, Natsoulis G, Boeke J
J Virol. 1996; 70(7):4329-37.
PMID: 8676455
PMC: 190365.
DOI: 10.1128/JVI.70.7.4329-4337.1996.
Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid domain: replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA.
Gorelick R, Chabot D, Ott D, Gagliardi T, Rein A, Henderson L
J Virol. 1996; 70(4):2593-7.
PMID: 8642691
PMC: 190107.
DOI: 10.1128/JVI.70.4.2593-2597.1996.
Mycobacterium avium complex infection in mice: lack of exacerbation after LP-BM5 murine leukemia virus infection.
Grassi F, Perronne C, Cohen Y, Maslo C, Chau F, Sinet M
Infect Immun. 1996; 64(4):1203-7.
PMID: 8606079
PMC: 173904.
DOI: 10.1128/iai.64.4.1203-1207.1996.
The significance of the pre-challenge immune status of mice for development of retrovirus-induced immunodeficiency syndrome (MAIDS).
Pavlovitch J, Rizk-Rabin M, Picard F, Marussig M, Halbreich A
Clin Exp Immunol. 1994; 96(1):64-8.
PMID: 8149668
PMC: 1534529.
DOI: 10.1111/j.1365-2249.1994.tb06231.x.
Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein.
Rein A, Mirro J, Haynes J, Ernst S, Nagashima K
J Virol. 1994; 68(3):1773-81.
PMID: 8107239
PMC: 236638.
DOI: 10.1128/JVI.68.3.1773-1781.1994.
